Manufacturing delays hit Takeda’s Vyvanse amid ADHD drug shortage
Takeda Pharmaceutical Company Limited is facing a manufacturing delay for its ADHD drug, Vyvanse, just as shortages for other ADHD drugs roil the country.
Other Articles in this Edition
What is ADHD in adults? A doctor answers
ADHD in Children: Focus on the Positives
About 15% of US children recently received mental health treatment, new CDC data shows
People who use ‘smart drugs’ worse at complex tasks, study finds
Manufacturing delays hit Takeda’s Vyvanse amid ADHD drug shortage
Senators propose ‘first step’ to address US drug shortages by examining supply chains
Investigating the Long-Term Safety of ADHD Medication for Children and Adolescents
Mixed Bag Phase 3 Data for ADHD Treatment Presented at ASHP Meeting
Attention Deficits are Not Just for Kids: Experiencing ADHD as an Adult